Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription


Articles published in J Natl Cancer Inst

Retrieve available abstracts of 32 articles:
HTML format
Text format



Single Articles


    November 2018
  1. YANG R, Li SW, Chen Z, Zhou X, et al
    Role of INSL4 Signaling in Sustaining the Growth and Viability of LKB1-Inactivated Lung Cancer.
    J Natl Cancer Inst. 2018 Nov 13. pii: 5181309. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2018
  2. HAHN EE, Gould MK
    Lung Cancer Screening and Smoking Cessation: Never Too Early or Too Late.
    J Natl Cancer Inst. 2018 May 16. pii: 4996950. doi: 10.1093.
    PubMed     Text format    


  3. TINDLE HA, Stevenson Duncan M, Greevy RA, Vasan RS, et al
    Lifetime Smoking History and Risk of Lung Cancer: Results From the Framingham Heart Study.
    J Natl Cancer Inst. 2018 May 16. pii: 4996947. doi: 10.1093.
    PubMed     Text format     Abstract available


  4. RAFNAR T, Sigurjonsdottir GR, Stacey SN, Halldorsson G, et al
    Association of BRCA2 K3326* With Small Cell Lung Cancer and Squamous Cell Cancer of the Skin.
    J Natl Cancer Inst. 2018 May 14. pii: 4995938. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2018
  5. NABI H, Provencher L, Diorio C
    RE: Smoking, Sex, and Non-Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424).
    J Natl Cancer Inst. 2018 Apr 20. pii: 4980806. doi: 10.1093.
    PubMed     Text format    


  6. VERMA V, Simone CB 2nd, Mishra MV
    Quality of Life and Patient-Reported Outcomes Following Proton Radiation Therapy: A Systematic Review.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


    March 2018
  7. SAMET JM
    Lung Cancer, Smoking, and Obesity: It's Complicated.
    J Natl Cancer Inst. 2018 Mar 6. pii: 4923351. doi: 10.1093.
    PubMed     Text format    


  8. YU D, Zheng W, Johansson M, Lan Q, et al
    Overall and Central Obesity and Risk of Lung Cancer: A Pooled Analysis.
    J Natl Cancer Inst. 2018 Mar 6. pii: 4923348. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2018
  9. CEDRES S, Felip E, Cruz C, Martinez de Castro A, et al
    Activity of HSP90 Inhibiton in a Metastatic Lung Cancer Patient With a Germline BRCA1 Mutation.
    J Natl Cancer Inst. 2018 Feb 26. pii: 4911464. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2018
  10. CHENG TD, Darke AK, Redman MW, Zirpoli GR, et al
    Smoking, Sex, and Non-Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424).
    J Natl Cancer Inst. 2018 Jan 13. pii: 4807490. doi: 10.1093.
    PubMed     Text format     Abstract available


  11. LIN SH, Koong AC
    Breathing New Life Into Hypoxia-Targeted Therapies for Non-Small Cell Lung Cancer.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format    


  12. SALEM A, Asselin MC, Reymen B, Jackson A, et al
    Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


  13. FANIDI A, Muller DC, Yuan JM, Stevens VL, et al
    Circulating Folate, Vitamin B6, and Methionine in Relation to Lung Cancer Risk in the Lung Cancer Cohort Consortium (LC3).
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


  14. MLECNIK B, Van den Eynde M, Bindea G, Church SE, et al
    Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


  15. JOHNSON SB, Park HS, Gross CP, Yu JB, et al
    Use of Alternative Medicine for Cancer and Its Impact on Survival.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


  16. HANLEY CJ, Mellone M, Ford K, Thirdborough SM, et al
    Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


    December 2017
  17. SONG MA, Benowitz NL, Berman M, Brasky TM, et al
    Cigarette Filter Ventilation and its Relationship to Increasing Rates of Lung Adenocarcinoma.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    November 2017
  18. BACH PB, Saltz LB
    Raising the Dose and Raising the Cost: The Case of Pembrolizumab in Lung Cancer.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    


  19. GOLDSTEIN DA, Gordon N, Davidescu M, Leshno M, et al
    A Phamacoeconomic Analysis of Personalized Dosing vs Fixed Dosing of Pembrolizumab in Firstline PD-L1-Positive Non-Small Cell Lung Cancer.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    October 2017
  20. PAGE BJ, Bowman RV, Yang IA, Fong KM, et al
    RE: Proportion of Never-Smoker Non-Small Cell Lung Cancer Patients at Three Diverse Institutions.
    J Natl Cancer Inst. 2017 Oct 16. doi: 10.1093.
    PubMed     Text format    


    September 2017
  21. DENIS F, Lethrosne C, Pourel N, Molinier O, et al
    Randomized Trial Comparing a Web-Mediated Follow-up With Routine Surveillance in Lung Cancer Patients.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


  22. CHAIB I, Karachaliou N, Pilotto S, Codony Servat J, et al
    Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    July 2017
  23. ZHOU B, Wang GZ, Wen ZS, Zhou YC, et al
    Somatic Mutations and Splicing Variants of Focal Adhesion Kinase in Non-Small Cell Lung Cancer.
    J Natl Cancer Inst. 2017 Jul 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  24. ROBLES AI, Harris CC
    Lung Cancer Field Cancerization: Implications for Screening by Low-Dose Computed Tomography.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    



  25. Shared Gene Expression Alterations in Nasal and Bronchial Epithelium for Lung Cancer Detection.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    June 2017
  26. KAWAKAMI M, Mustachio LM, Rodriguez-Canales J, Mino B, et al
    Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung Cancer.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


  27. LEE CK, Davies L, Wu YL, Mitsudomi T, et al
    Gefitinib or Erlotinib vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall Survival.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    March 2017
  28. XU W, Neckers L
    Editorial: A USE1ful Biomarker and Molecular Target in Lung Cancer?
    J Natl Cancer Inst. 2017;109:1-3.
    PubMed     Text format    


  29. WELLER M, Roth P, Sahm F, Burghardt I, et al
    Durable Control of Metastatic AKT1-Mutant WHO Grade 1 Meningothelial Meningioma by the AKT Inhibitor, AZD5363.
    J Natl Cancer Inst. 2017;109:1-4.
    PubMed     Text format     Abstract available


  30. KIM SJ, Hyeong Lee T, Hee Nam S, Kim JH, et al
    Association of Uba6-Specific-E2 (USE1) With Lung Tumorigenesis.
    J Natl Cancer Inst. 2017;109:1-11.
    PubMed     Text format     Abstract available


  31. CELIKTAS M, Tanaka I, Tripathi SC, Fahrmann JF, et al
    Role of CPS1 in Cell Growth, Metabolism, and Prognosis in LKB1-Inactivated Lung Adenocarcinoma.
    J Natl Cancer Inst. 2017;109:1-9.
    PubMed     Text format     Abstract available


    January 2017
  32. SHUKLA S, Evans JR, Malik R, Feng FY, et al
    Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: